Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G for VOR Biopharma Inc. Common Stock, 0.0001 par value per share (VOR).
- Disclosed ownership: 8.6%.
- Date of event: 11 Nov 2025.
Paradigm Biocapital Advisors LP - 11 Nov 2025 SCHEDULE 13G Report for VOR Biopharma Inc. Common Stock, 0.0001 par value per share (VOR)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- VOR
- Shares outstanding
- 20,348,837 shares
- Disclosed Ownership
- 1,750,000 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Nov 2025, 16:30:06 UTC
- Date of event
- 11 Nov 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 8.6% ownership in VOR Biopharma Inc. Common Stock, 0.0001 par value per share (VOR) on 11 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Nov 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 8.6% | 1,750,000 | 1,750,000 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 8.6% | 1,750,000 | 1,750,000 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 8.6% | 1,750,000 | 1,750,000 | 0 | /s/ Senai Asefaw, M.D. | Senai Asefaw, M.D. | |
| Paradigm BioCapital International Fund Ltd. | 7.6% | 1,546,061 | 1,546,061 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |